Vegzelma

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72606-012
  • Package NDC 72606-012-01
  • Package NDC 72606-012-10
  • Application number BLA761268
  • SPL ID 598b7687-6daa-2ce7-e063-6394a90ab429
  • SPL set ID 4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe
  • UNII 2S9ZZM9Q9V
  • RxCUI 2627650
  • RxCUI 2627656
  • RxCUI 2627658
  • RxCUI 2627659

What the source publishes

Labeler
CELLTRION USA, Inc.
Active ingredients
bevacizumab-adcd
Form
INJECTION, SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72606-012_598b7687-6daa-2ce7-e063-6394a90ab429
{
  "name": "Vegzelma",
  "splId": "598b7687-6daa-2ce7-e063-6394a90ab429",
  "labels": [
    {
      "setId": "4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "CELLTRION USA, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-USE in 1 CARTON (72606-012-01)  / 16 mL in 1 VIAL, SINGLE-USE",
      "package_ndc": "72606-012-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230403"
    },
    {
      "sample": false,
      "description": "10 VIAL, SINGLE-USE in 1 CARTON (72606-012-10)  / 16 mL in 1 VIAL, SINGLE-USE",
      "package_ndc": "72606-012-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230403"
    }
  ],
  "productId": "72606-012_598b7687-6daa-2ce7-e063-6394a90ab429",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "72606-012",
  "deaSchedule": null,
  "genericName": "bevacizumab-adcd",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BEVACIZUMAB",
      "strength": "400 mg/16mL"
    }
  ],
  "applicationNumber": "BLA761268",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230403",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000193543",
      "N0000178291",
      "N0000193542"
    ],
    "unii": [
      "2S9ZZM9Q9V"
    ],
    "rxcui": [
      "2627650",
      "2627656",
      "2627658",
      "2627659"
    ],
    "spl_set_id": [
      "4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe"
    ],
    "pharm_class_epc": [
      "Vascular Endothelial Growth Factor Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
      "Vascular Endothelial Growth Factor Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "CELLTRION USA, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72606-012_598b7687-6daa-2ce7-e063-6394a90ab429"